BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29683859)

  • 21. 99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study.
    Signore A; Annovazzi A; Barone R; Bonanno E; D'Alessandria C; Chianelli M; Mather SJ; Bottoni U; Panetta C; Innocenzi D; Scopinaro F; Calvieri S
    J Nucl Med; 2004 Oct; 45(10):1647-52. PubMed ID: 15471828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8
    Luo J; Shi X; Liu Y; Wang J; Wang H; Yang X; Sun Q; Hui Z; Wei F; Ren X; Zhao H
    Front Immunol; 2024; 15():1302761. PubMed ID: 38390332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma.
    Park CK; Kim SK
    Oncotarget; 2017 Feb; 8(9):14759-14769. PubMed ID: 28107203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectopic lymphoid structures in primary cutaneous melanoma.
    Ladányi A; Sebestyén T; Mohos A; Liszkay G; Somlai B; Tóth E; Tímár J
    Pathol Oncol Res; 2014 Oct; 20(4):981-5. PubMed ID: 24781762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
    Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
    Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy.
    Asrir A; Tardiveau C; Coudert J; Laffont R; Blanchard L; Bellard E; Veerman K; Bettini S; Lafouresse F; Vina E; Tarroux D; Roy S; Girault I; Molinaro I; Martins F; Scoazec JY; Ortega N; Robert C; Girard JP
    Cancer Cell; 2022 Mar; 40(3):318-334.e9. PubMed ID: 35120598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases.
    Cipponi A; Mercier M; Seremet T; Baurain JF; Théate I; van den Oord J; Stas M; Boon T; Coulie PG; van Baren N
    Cancer Res; 2012 Aug; 72(16):3997-4007. PubMed ID: 22850419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte recruitment via high endothelial venules in lymphoid stroma of Warthin's tumour.
    Ohya A; Kobayashi M; Sakai Y; Kawashima H; Kageyama S; Nakayama J
    Pathology; 2013 Feb; 45(2):150-4. PubMed ID: 23250041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphoid tissue- and inflammation-specific endothelial cell differentiation defined by monoclonal antibodies.
    Duijvestijn AM; Kerkhove M; Bargatze RF; Butcher EC
    J Immunol; 1987 Feb; 138(3):713-9. PubMed ID: 3543117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma.
    Ladányi A; Mohos A; Somlai B; Liszkay G; Gilde K; Fejos Z; Gaudi I; Tímár J
    Pathol Oncol Res; 2010 Sep; 16(3):303-9. PubMed ID: 20306313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor.
    Leslie C; Bowyer SE; White A; Grieu-Iacopetta F; Trevenen M; Iacopetta B; Amanuel B; Millward M
    Pathology; 2015 Oct; 47(6):557-63. PubMed ID: 26308130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Examination of different factors influencing the vascularization of human cutaneous melanoma].
    Kiss J
    Magy Onkol; 2008 Dec; 52(4):385-9. PubMed ID: 19068467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of a sulfotransferase (HEC-GlcNAc6ST) in high endothelial venules of lymph nodes and in high endothelial venule-like vessels within ectopic lymphoid aggregates: relationship to the MECA-79 epitope.
    Bistrup A; Tsay D; Shenoy P; Singer MS; Bangia N; Luther SA; Cyster JG; Ruddle NH; Rosen SD
    Am J Pathol; 2004 May; 164(5):1635-44. PubMed ID: 15111310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy.
    Bravo AI; Aris M; Panouillot M; Porto M; Dieu-Nosjean MC; Teillaud JL; Barrio MM; Mordoh J
    Front Immunol; 2023; 14():1231734. PubMed ID: 37691949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of tumour-infiltrating CD25+FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma.
    Miracco C; Mourmouras V; Biagioli M; Rubegni P; Mannucci S; Monciatti I; Cosci E; Tosi P; Luzi P
    Oncol Rep; 2007 Nov; 18(5):1115-22. PubMed ID: 17914561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The vast majority of lymphocytes infiltrating primary cutaneous melanoma express the CD27 costimulatory receptor: implications for melanoma progression.
    Pepe CA; Ricci R; Cortelazzi C; Mori G; Zambito F; Campanini N; Aimi F; Santoro S; Lombardi M; Santini M; de Panfilis G
    Eur J Dermatol; 2011; 21(2):178-83. PubMed ID: 21382782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
    Chevolet I; Speeckaert R; Haspeslagh M; Neyns B; Krüse V; Schreuer M; Van Gele M; Van Geel N; Brochez L
    Br J Dermatol; 2014 Nov; 171(5):987-95. PubMed ID: 24814041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High percentage of ADAM-10 positive melanoma cells correlates with paucity of tumor-infiltrating lymphocytes but does not predict prognosis in cutaneous melanoma patients.
    Donizy P; Zietek M; Leskiewicz M; Halon A; Matkowski R
    Anal Cell Pathol (Amst); 2015; 2015():975436. PubMed ID: 26266086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma.
    Ladányi A
    Pigment Cell Melanoma Res; 2015 Sep; 28(5):490-500. PubMed ID: 25818762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.